# Pregnancy Registry to Collect Long-Term Safety Data From Women Treated With HyQvia

> **NCT02556775** · — · COMPLETED · sponsor: **Baxalta now part of Shire** · enrollment: 16 (actual)

## Conditions studied

- Exposure During Pregnancy

## Interventions

- **BIOLOGICAL:** A licensed human normal immunoglobulin other than HYQVIA for IV or SC infusion or an alternative treatment
- **BIOLOGICAL:** HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase]

## Key facts

- **NCT ID:** NCT02556775
- **Lead sponsor:** Baxalta now part of Shire
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-04
- **Primary completion:** 2019-12-17
- **Final completion:** 2019-12-17
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2021-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02556775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02556775, "Pregnancy Registry to Collect Long-Term Safety Data From Women Treated With HyQvia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02556775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*